Two sickle cell disease researchers will share a $3 million Breakthrough Prize for discoveries that changed the treatment ...

Etavopivat improved hemoglobin levels and reduced pain crises in a Phase 3 sickle cell disease trial, supporting potential ...

Newly diagnosed with DVT and a pulmonary embolism, columnist Michelle Harlan finds herself in an unfamiliar relationship with ...

Having a remote job has been a game-changer for me as someone with sickle cell disease. I’m better able to manage my health — no rushed mornings, cold commutes, or physical strain. I can plan my day ...

People with sickle cell disease in Africa are less likely to use common treatments and may report lower burden, a global ...

Bias in sickle cell care may be tied to opioid stigma, with patients more often described negatively in medical records, a ...

The isolation of chronic disease isn't just about being physically alone; it's also emotional and social, says columnist ...

Agios Pharmaceuticals is planning to file an application with the U.S. Food and Drug Administration (FDA) in the coming months that will seek accelerated approval of its oral therapy mitapivat for ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Children with sickle cell anemia (SCA), the most common and ...

The Japan Agency for Medical Research and Development (AMED) — a national funding agency created to support medical R&D in the Asian nation — has awarded up to $32 million to Epifrontier Therapeutics ...